Name
EphB1+EphB2+EphB3+EphB4 Antibody, Cy3 Conjugated
Catalog number
bs-7045R-Cy3
Size
0.1ml
Price
350 EUR
Conjugation
Cy3
Gene ID number
2047
Modification site
None
Crossreactivity
Human
Tested applications
IF(IHC-P)
French translation
anticorps
Modification
Unmodified
Clonality
Polyclonal
Concentration
1ug per 1ul
Clone
Polyclonal antibody
Additional conjugation
cy3 conjugation kit
Excitation Emission
512,550nm/570,615nm
Recommended dilutions
IF(IHC-P)(1:50-200)
Target Antigen
EphB1+EphB2+EphB3+EphB4
Category
Conjugated Primary Antibodies
Host Organism
Rabbit (Oryctolagus cuniculus)
Purification method
This antibody was purified via Protein A.
Long name
EphB1+EphB2+EphB3+EphB4 Antibody, Cy3 Conjugated
Specificity
This is a highly specific antibody against EphB1+EphB2+EphB3+EphB4.
Source
KLH conjugated synthetic peptide derived from human EphB1+EphB2+EphB3+EphB4
Crossreactive species details
Due to limited amount of testing and knowledge, not every possible cross-reactivity is known.
Storage conditions
Keep the antibody in an aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide. Store refrigerated at 2 to 8 degrees Celcius for up to 1 year.
Antigen background
Receptor for members of the ephrin-B family. Binds to ephrin-B1, -B2 and -B3. Binding with the guidance cue ephrin-B2 at the optic chiasm midline redirect ventrotemporal (VT) retinal ganglion cells (RGCs) axons ipsilaterally. May be involved in cell-cell interactions in the nervous system.
Properties
If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24°C for long term storage and for short term at + 5°C.Cy3 antibodies are excited by the 488-nanometer wave of an argon laser and the 633-nanometer line of a helium-neon diode laser. 1 of the Anti-EphB1+EphB2+EphB3+EphB4 can be used in flow cytometry but typically shows lower fluorescence intensity comparable to that of PE or APC. This Bioss Primary Conjugated Antibodies antibody is well suited for fluorescent microscopy.
Synonyms
CAPB;DRT;EK2;EK5;EK6;ELK;elk related tyrosine kinase;EPH like kinase 2;EPH like kinase 6;EPH like tyrosine kinase 2;eph tyrosine kinase 2;eph tyrosine kinase 3;EPH-like kinase 6;Ephb1;EPHB1_HUMAN;EPHB2;EPHB3;EPHB4;ephrin receptor EphB4;ephrin type B receptor 1;ephrin type B receptor 2;ephrin type B receptor 3;ephrin type B receptor 4;Ephrin type-B receptor 1;EPHT2;EPHT3;ERK;ETK2;Hek 5;Hek 6;HEK2;HEK5;HEK6;hepatoma transmembrane kinase;HTK;human embryo kinase 2;MYK1;NET;PCBC;protein tyrosine kinase HEK5;renal carcinoma antigen NY REN 47;soluble EPHB1 variant 1;soluble EPHB4 variant 1;soluble EPHB4 variant 2;soluble EPHB4 variant 3;TYRO11;Tyro5;TYRO6;tyrosine protein kinase receptor EPH 2;tyrosine protein kinase receptor EPH 3;tyrosine protein kinase receptor EPH2;tyrosine protein kinase receptor EPH3;tyrosine protein kinase receptor HTK;tyrosine protein kinase TYRO11;tyrosine protein kinase TYRO5;tyrosine protein kinase TYRO6;Tyrosine-protein kinase receptor EPH-2.